Literature DB >> 12100157

Hyperlipidaemia and venous thromboembolism in patients lacking thrombophilic risk factors.

Amparo Vayá1, Yolanda Mira, Fernando Ferrando, MaTeresa Contreras, Amparo Estelles, Francisco España, Dolores Corella, Justo Aznar.   

Abstract

To ascertain the potential contribution of serum lipids to the development of deep vein thrombosis (DVT), a case-control study was conducted in 143 DVT patients lacking thrombophilic risk factors and in 194 age- and sex-matched controls. DVT patients showed significantly higher body mass indices (BMI), and triglyceride levels than did controls (P < 0.001 and P = 0.045 respectively). Using multivariate analysis, BMI was the only variable which remained statistically different, thus the risk of DVT was associated with obesity (odds ratio = 2.49). These results were confirmed when additional control for fibrinogen and plasminogen activator inhibitor type 1 (PAI-1) was carried out in a subgroup of cases and controls. When idiopathic (n = 39) and secondary (n = 104) patients with DVT were compared, the former showed a higher mean age, a higher proportion of men, and higher cholesterol levels. Age, sex and total cholesterol were statistically different by multivariate analysis. After age was dichotomized as >or= 50 years and cholesterol >or= 5.69 mmol/l, all three variables constituted independent risk factors for idiopathic DVT, with odds ratios of 2.73 for ages >or= 50 years; 3.72 for men and 2.67 for cholesterolaemia >or= 5.69 mmol/l. Obesity thus constitutes an independent risk factor for DVT, possibly in part mediated through triglyceride, fibrinogen and PAI-1 effects on haemostasis. In addition, cholesterolaemia levels of >or= 5.69 mmol/l constitute an independent risk factor for idiopathic DVT.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12100157     DOI: 10.1046/j.1365-2141.2002.03563.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  18 in total

Review 1.  Risk factors for venous and arterial thrombosis.

Authors:  Emanuele Previtali; Paolo Bucciarelli; Serena M Passamonti; Ida Martinelli
Journal:  Blood Transfus       Date:  2010-10-25       Impact factor: 3.443

2.  Dyslipidaemia in Behcet's disease as a thrombotic risk factor.

Authors:  J M Ricart; A Vayá; M Santaolaria; F España; J Aznar
Journal:  Ann Rheum Dis       Date:  2006-09       Impact factor: 19.103

Review 3.  Review: thromboses among HIV-infected patients during the highly active antiretroviral therapy era.

Authors:  Nancy F Crum-Cianflone; Jhamillia Weekes; Mary Bavaro
Journal:  AIDS Patient Care STDS       Date:  2008-10       Impact factor: 5.078

4.  Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control study.

Authors:  Aneel A Ashrani; Michel K Barsoum; Daniel J Crusan; Tanya M Petterson; Kent R Bailey; John A Heit
Journal:  Thromb Res       Date:  2015-04-11       Impact factor: 3.944

Review 5.  Is there a Link Between Atherothrombosis and Deep Venous Thrombosis?

Authors:  Maria-Cristina Andrei; Aurel Andercou
Journal:  Maedica (Buchar)       Date:  2014-03

6.  Lipid biomarkers, hormone therapy and the risk of venous thromboembolism in women.

Authors:  B M Everett; R J Glynn; J E Buring; P M Ridker
Journal:  J Thromb Haemost       Date:  2009-01-24       Impact factor: 5.824

7.  Thrombophilic factors are not the leading cause of thrombosis in Behçet's disease.

Authors:  M Leiba; U Seligsohn; Y Sidi; D Harats; B A Sela; J H Griffin; A Livneh; N Rosenberg; I Gelernter; H Gur; M Ehrenfeld
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

8.  Inflammatory plasma markers and risk for venous thromboembolism.

Authors:  Signy V Sveinsdottir; Peter J Svensson; Gunnar Engström
Journal:  J Thromb Thrombolysis       Date:  2014       Impact factor: 2.300

9.  Exploration of high-risk factors for pulmonary embolism in patients undergoing postoperative anti-thrombotic therapy among gynecologic oncology surgery: a retrospective study.

Authors:  Tongyu Liu; Shao-Wei Lin; Su Lin; Lin Yang; Haizhou Ji; Jianping Zou; Rong Xie
Journal:  Ann Transl Med       Date:  2019-04

10.  Influence of lipid metabolism disorders on venous thrombosis risk.

Authors:  Igor Spasić; Milan Ubavić; Zorica Šumarac; Maša Todorović; Biljana Vučković
Journal:  J Med Biochem       Date:  2021-06-05       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.